These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
248 related items for PubMed ID: 11018640
1. Cyclin-dependent kinase inhibitor P27(KIP1) is expressed preferentially in early stages of urothelial carcinoma. Franke KH, Miklosi M, Goebell P, Clasen S, Steinhoff C, Anastasiadis AG, Gerharz C, Schulz WA. Urology; 2000 Oct 01; 56(4):689-95. PubMed ID: 11018640 [Abstract] [Full Text] [Related]
2. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features. Ioachim E, Michael M, Stavropoulos NE, Kitsiou E, Hastazeris K, Salmas M, Stefanaki S, Agnantis NJ. Urol Int; 2004 Oct 01; 73(1):65-73. PubMed ID: 15263796 [Abstract] [Full Text] [Related]
3. Expression of p27(KIP1) and p21(WAF1/CIP1) in primary hepatocellular carcinoma: clinicopathologic correlation and survival analysis. Qin LF, Ng IO. Hum Pathol; 2001 Aug 01; 32(8):778-84. PubMed ID: 11521219 [Abstract] [Full Text] [Related]
5. Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival. Del Pizzo JJ, Borkowski A, Jacobs SC, Kyprianou N. Am J Pathol; 1999 Oct 01; 155(4):1129-36. PubMed ID: 10514396 [Abstract] [Full Text] [Related]
7. Combined examination of p27(Kip1), p21(Waf1/Cip1) and p53 expression allows precise estimation of prognosis in patients with gastric carcinoma. Liu XP, Kawauchi S, Oga A, Suehiro Y, Tsushimi K, Tsushimi M, Sasaki K. Histopathology; 2001 Dec 01; 39(6):603-10. PubMed ID: 11903579 [Abstract] [Full Text] [Related]
8. Expression of cell cycle proteins in T1a and T1b urothelial bladder carcinoma and their value in predicting tumor progression. Mhawech P, Greloz V, Oppikofer C, Szalay-Quinodoz I, Herrmann F. Cancer; 2004 Jun 01; 100(11):2367-75. PubMed ID: 15160340 [Abstract] [Full Text] [Related]
10. Increased expression of cyclin D1, cyclin E and p21(Cip1) associated with decreased expression of p27(Kip1) in chemically induced rat mammary carcinogenesis. Jang TJ, Kang MS, Kim H, Kim DH, Lee JI, Kim JR. Jpn J Cancer Res; 2000 Dec 01; 91(12):1222-32. PubMed ID: 11123420 [Abstract] [Full Text] [Related]
11. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1. Korkolopoulou P, Christodoulou P, Konstantinidou AE, Thomas-Tsagli E, Kapralos P, Davaris P. Hum Pathol; 2000 Jun 01; 31(6):751-60. PubMed ID: 10872671 [Abstract] [Full Text] [Related]
12. Cyclin D1 expression in papillary superficial bladder cancer: its association with other cell cycle-associated proteins, cell proliferation and clinical outcome. Sgambato A, Migaldi M, Faraglia B, De Aloysio G, Ferrari P, Ardito R, De Gaetani C, Capelli G, Cittadini A, Trentini GP. Int J Cancer; 2002 Feb 10; 97(5):671-8. PubMed ID: 11807796 [Abstract] [Full Text] [Related]
14. Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer. Kamai T, Takagi K, Asami H, Ito Y, Oshima H, Yoshida KI. Br J Cancer; 2001 May 04; 84(9):1242-51. PubMed ID: 11336477 [Abstract] [Full Text] [Related]
15. Persistent and heterogenous expression of the cyclin-dependent kinase inhibitor, p27KIP1, in rat hearts during development. Koh KN, Kang MJ, Frith-Terhune A, Park SK, Kim I, Lee CO, Koh GY. J Mol Cell Cardiol; 1998 Mar 04; 30(3):463-74. PubMed ID: 9515024 [Abstract] [Full Text] [Related]
16. Significance of p57(Kip2) down-regulation in oncogenesis of bladder carcinoma: an immunohistochemical study. Bozdoğan O, Atasoy P, Batislam E, Başar MM, Başar H. Tumori; 2008 Mar 04; 94(4):556-62. PubMed ID: 18822693 [Abstract] [Full Text] [Related]
17. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer. Masciullo V, Sgambato A, Pacilio C, Pucci B, Ferrandina G, Palazzo J, Carbone A, Cittadini A, Mancuso S, Scambia G, Giordano A. Cancer Res; 1999 Aug 01; 59(15):3790-4. PubMed ID: 10446997 [Abstract] [Full Text] [Related]
18. Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade. Guo Y, Sklar GN, Borkowski A, Kyprianou N. Clin Cancer Res; 1997 Dec 01; 3(12 Pt 1):2269-74. PubMed ID: 9815624 [Abstract] [Full Text] [Related]
19. High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers. Fredersdorf S, Burns J, Milne AM, Packham G, Fallis L, Gillett CE, Royds JA, Peston D, Hall PA, Hanby AM, Barnes DM, Shousha S, O'Hare MJ, Lu X. Proc Natl Acad Sci U S A; 1997 Jun 10; 94(12):6380-5. PubMed ID: 9177226 [Abstract] [Full Text] [Related]
20. p21, p27, cyclin D1, and p53 in rectal cancer: immunohistology with prognostic significance? Schwandner O, Bruch HP, Broll R. Int J Colorectal Dis; 2002 Jan 10; 17(1):11-9. PubMed ID: 12018448 [Abstract] [Full Text] [Related] Page: [Next] [New Search]